Content related to Will N-Acetylcysteine Be the Next Therapy to Prevent Cisplatin-Induced Hearing Loss?

A key study led by Dr. David Freyer showed that sodium thiosulfate prevented cisplatin-related hearing loss in children and led to therapy approval.

A new survey endorses the value of cancer survivorship care but finds that many adult patients aren’t accessing it.

A CHLA oncologist is leading new research to improve outcomes for children, adolescents and young adults with relapsed or treatment-resistant germ cell tumors.

Study shows that combining MIBG therapy with immunotherapy and vorinostat may boost response rates in patients with relapsed neuroblastoma.

Four investigators share their research—and how the USC/CHLA facility will help bring novel cell therapies to clinical trials faster.

Hunter never let his acute lymphoblastic leukemia diagnosis define him—but today, he proudly wears the title “survivor” in support of cancer research.

The ambitions of pediatric researchers are global in scale: Beyond patients at their own hospital, they look to shape national and international standards for pediatric care.

In a new paper from Neurocrine Biosciences, CHLA’s Dr. Mimi Kim and collaborators explore using the drug crinecerfont to treat congenital adrenal hyperplasia.

Screening for substance abuse in the emergency department can flag at-risk adolescents who need interventions, but not everyone gets screened.